Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma (Q35051799)

6 August 2017

Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma (English)

1 reference

6 August 2017

0 references

Akira Watanabe

1

1 reference

6 August 2017

Hideki Suzuki

2

1 reference

6 August 2017

Takehiko Yokobori

3

1 reference

6 August 2017

Mariko Tsukagoshi

4

1 reference

6 August 2017

Bolag Altan

5

1 reference

6 August 2017

Norio Kubo

6

1 reference

6 August 2017

Shigemasa Suzuki

7

1 reference

6 August 2017

Kenichiro Araki

8

1 reference

6 August 2017

Satoshi Wada

9

1 reference

6 August 2017

Kenji Kashiwabara

10

1 reference

6 August 2017

Yasuo Hosouchi

11

1 reference

6 August 2017

Hiroyuki Kuwano

12

1 reference

6 August 2017

27 May 2014

1 reference

6 August 2017

1 reference

6 August 2017

105

1 reference

6 August 2017

6

1 reference

6 August 2017

690-696

1 reference

Nuclear karyopherin-α2 expression in primary lesions and metastatic lymph nodes was associated with poor prognosis and progression in gastric cancer

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317896

Specific small molecule inhibitors of Skp2-mediated p27 degradation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317896

Modern diagnostic approaches to cholangiocarcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317896

Stathmin1 plays oncogenic role and is a target of microRNA-223 in gastric cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317896

Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317896

Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317896

Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317896

Overexpression of stathmin1 in the diffuse type of gastric cancer and its roles in proliferation and migration of gastric cancer cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317896

A cohort study of STMN1 expression in colorectal cancer: body mass index and prognosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317896

Protumorigenic overexpression of stathmin/Op18 by gain-of-function mutation in p53 in human hepatocarcinogenesis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317896

Increased expression and differential phosphorylation of stathmin may promote prostate cancer progression

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317896

Stathmin is overexpressed in malignant mesothelioma.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317896

Reversal of stathmin-mediated resistance to paclitaxel and vinblastine in human breast carcinoma cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317896

Silencing of stathmin induces tumor-suppressor function in breast cancer cell lines harboring mutant p53.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317896

Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumour progression and poor prognosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317896

p27(Kip1) and stathmin share the stage for the first time

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317896

p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317896

Cip/Kip proteins: more than just CDKs inhibitors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317896

Altered levels and regulation of stathmin in paclitaxel-resistant ovarian cancer cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317896

What constitutes long-term survival after surgery for hilar cholangiocarcinoma?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317896

Surgical treatment in proximal bile duct cancer. A single-center experience

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317896

Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317896

Degradation of p27(Kip1) at the G(0)-G(1) transition mediated by a Skp2-independent ubiquitination pathway

8 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FCAS.12417

Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317896

Expression of Stathmin in Localized Upper Urinary Tract Urothelial Carcinoma: Correlations With Prognosis

25 October 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FCAS.12417

Prognostic significance of CD151 expression in esophageal squamous cell carcinoma with aggressive cell proliferation and invasiveness

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24708177

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Taxol and anti-stathmin therapy: a synergistic combination that targets the mitotic spindle

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24708177

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Stathmin1 overexpression associated with polyploidy, tumor-cell invasion, early recurrence, and poor prognosis in human hepatoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24708177

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/CAS.12417

1 reference

6 August 2017

1 reference

6 August 2017

1 reference